SEC Tracker
Get the app

Zai Lab ZLAB

Zai Lab raises $250M via private placement

Item 1.01 Enters material agreement, Item 3.02 Unregistered share sale, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. Sold 11,340,000 ADSs at $22.04 per share
  2. Expected proceeds of $250M before fees
  3. Intends to use funds for pipeline development and working capital
  4. Closing expected October 27, 2026

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Zai Lab files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Rhythm Pharmaceuticals RYTM public float $3.8B, Jun 30, 2025
  2. Vaxcyte PCVX public float $3.7B, Jun 30, 2025
  3. PERRIGO PRGO public float $3.7B, Jun 27, 2025
  4. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025
  5. Adma Biologics ADMA public float $4.2B, Jun 30, 2025